EE412 Real-World Cost-Effectiveness Analysis of Ustekinumab-Based Therapies Vs Non-Biologic Therapies for Moderate to Severe Crohn’s Disease in Chinese Population
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.708
https://www.valueinhealthjournal.com/article/S1098-3015(24)00823-4/fulltext
Title :
EE412 Real-World Cost-Effectiveness Analysis of Ustekinumab-Based Therapies Vs Non-Biologic Therapies for Moderate to Severe Crohn’s Disease in Chinese Population
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00823-4&doi=10.1016/j.jval.2024.03.708
First page :
Section Title :
Open access? :
No
Section Order :
10175